This page shows the latest FMF news and features for those working in and with pharma, biotech and healthcare.
Its label now includes Tumor Necrosis Factor-Receptor Associated Periodic Syndrome (TARPS), Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency (HIDS/MKD), and Familial Mediterranean Fever (FMF).
FMF) and tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
Other uses being assessed include tumour necrosis factor receptor-associated periodic syndrome (TRAPS), colchicine-resistant familial Mediterranean fever (FMF) and hyper IgD syndrome (HIDS), and analysts have suggested that - collectively - the
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...